Wits Vaccines and Infectious Diseases Analytics (VIDA)

Image sourced from TimesLIVE Pfizer is set to distribute 20 million doses of its COVID-19 Vaccine to South Africa – starting mid-April. This comes after the pharmaceutical company managed to resolve contractual conditions that weren’t in line with South Africa’s normal procurement policies, revealed Department of Health deputy director-general, Anban Pillay. According to Bloomberg, the Pfizer-BioNTech version will be “used to kick-start the rollout after a decision not to use AstraZeneca Plc’s shot, which was found to offer little protection against mild forms of COVID-19 in a local trial”. AstraZeneca Vaccine Only ‘Minimally Effective’ Against South African COVID-19 Variant, says Researcher The AstraZeneca COVID-19 vaccine has proven ‘minimally effective’ against the South African variant...